Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
GOVX GeoVax Labs Inc
- Stocks
- Healthcare
- NASDAQ: GOVX
Price (delayed)
$0.9848
Market cap
$14.96M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.65
Enterprise value
$7.52M
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On
Highlights
The EPS has soared by 75% year-on-year and by 24% since the previous quarter
The equity has surged by 56% since the previous quarter
Key stats
What are the main financial stats of GOVX
Market
Valuations
Earnings
Shares outstanding
15.19M
Market cap
$14.96M
Enterprise value
$7.52M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.73
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$30.26M
Net income
-$24.5M
EBIT
-$24.48M
EBITDA
-$24.39M
Free cash flow
-$25M
Per share
Balance sheet
Liquidity
EPS
-$3.65
EPS diluted
-$3.65
Free cash flow per share
-$2.09
Book value per share
$0.57
Revenue per share
$0
TBVPS
$0.91
Total assets
$10.83M
Total liabilities
$2.94M
Debt
$0
Equity
$7.9M
Working capital
$7.68M
Debt to equity
0
Current ratio
3.62
Quick ratio
3.04
Net debt/EBITDA
0.31
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-286.6%
Return on equity
-512%
Return on invested capital
N/A
Return on capital employed
-309.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GOVX stock price
How has the GeoVax Labs stock price performed over time
Intraday
8.51%
1 week
6.17%
1 month
9.13%
1 year
-43.4%
YTD
-60.13%
QTD
-7.09%
Financial performance
How have GeoVax Labs's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$30.26M
Net income
-$24.5M
Gross margin
N/A
Net margin
N/A
GeoVax Labs's net income has increased by 12% YoY
The operating income has contracted by 7% YoY and by 4% from the previous quarter
Price vs fundamentals
How does GOVX's price correlate with its fundamentals
Growth
What is GeoVax Labs's growth rate over time
Valuation
What is GeoVax Labs stock price valuation
P/E
N/A
P/B
1.73
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 75% year-on-year and by 24% since the previous quarter
The P/B is 71% less than the 5-year quarterly average of 6.0
The equity has surged by 56% since the previous quarter
Efficiency
How efficient is GeoVax Labs business performance
The return on equity has declined by 48% year-on-year but it rose by 42% since the previous quarter
The ROA has declined by 29% year-on-year but it rose by 23% since the previous quarter
Dividends
What is GOVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GOVX.
Financial health
How did GeoVax Labs financials performed over time
The quick ratio has soared by 54% from the previous quarter
The current ratio is up by 42% since the previous quarter
The debt is 100% smaller than the equity
The equity has surged by 56% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.